AIFM1, negatively regulated by miR-145-5p, aggravates hypoxia-induced cardiomyocyte injury

Wugang Zhou1, Lv Ji2, Xuqin Liu2

  • 1Department of Emergency, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Intensive Care Unit, Shigatse People's Hospital, Shigatse, Tibet Autonomous Region, China.

Biomedical Journal
|December 5, 2021
PubMed
Abstract

Insights

Apoptosis-inducing factor mitochondria associated 1 (AIFM1) exacerbates myocardial infarction by promoting inflammation and cardiomyocyte injury. Its upregulation is linked to decreased miR-145-5p levels, suggesting a novel therapeutic target for heart attack.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Pathology

Background:

  • Hypoxia-induced apoptosis is a key factor in myocardial infarction pathogenesis.
  • The specific role of apoptosis-inducing factor mitochondria associated 1 (AIFM1) in cardiomyocyte injury is not well understood.

Purpose of the Study:

  • To investigate the role of AIFM1 in myocardial injury.
  • To elucidate the regulatory mechanism of AIFM1 in the context of myocardial infarction.

Main Methods:

  • Utilized H9c2 cardiomyocytes and a mouse model of myocardial infarction.
  • Assessed AIFM1 and miR-145-5p expression via qRT-PCR and protein levels via Western blot.
  • Evaluated cell viability and apoptosis markers, and confirmed the interaction between AIFM1 and miR-145-5p.

Main Results:

  • AIFM1 expression was significantly upregulated, while miR-145-5p was downregulated in myocardial infarction models.
  • Increased AIFM1 reduced cell viability and increased inflammatory markers and cleaved caspase-3.
  • AIFM1 was identified as a direct target of miR-145-5p, and the miR-145-5p/AIFM1 axis influenced p53 expression.

Conclusions:

  • AIFM1 exacerbates myocardial ischemic injury by promoting inflammation and cardiomyocyte damage.
  • Upregulation of AIFM1 may be partly attributed to the downregulation of miR-145-5p, highlighting a potential therapeutic pathway.